← Back to Search

VitalCare Platform

Remote Patient Monitoring for Heart Failure (FAST-RPM-HF Trial)

N/A
Waitlist Available
Research Sponsored by Saint Luke's Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
New York Heart Association Class II or III congestive HF symptoms
A clinical diagnosis of heart failure
Must not have
NYHA Class I or IV congestive HF symptoms
End-stage renal disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month
Awards & highlights
No Placebo-Only Group

Summary

This trial will be the first to study the effect of remote patient monitoring with the VitalCare platform on outcomes of ambulatory heart failure patients.

Who is the study for?
This trial is for adults with heart failure who've been hospitalized for it within the last year, can use a smartphone or tablet, and speak English. It's not for pregnant individuals, those awaiting a heart transplant, with severe kidney disease or very poor heart function (LVEF < 35%), or have certain implanted cardiac devices.
What is being tested?
The study tests the VitalCare platform's ability to monitor heart failure patients remotely. It aims to see if this technology improves patient engagement and reduces hospital visits due to worsening heart failure.
What are the potential side effects?
Since this trial involves remote monitoring rather than medication, traditional side effects are not expected. However, there may be privacy concerns or stress related to constant health tracking.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have moderate heart failure symptoms.
Select...
I have been diagnosed with heart failure.
Select...
I was hospitalized for heart failure symptoms within the last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My heart failure symptoms are mild or very severe.
Select...
My kidneys are in the final stage of failure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compliance with monitoring protocol
Secondary study objectives
Heart failure hospitalizations, emergency room visits for Heart Failure as compared to prior to trial enrollment
Patient engagement as measured by Patient Activation Measure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionalExperimental Treatment1 Intervention
All patients receive the VitalCare platform with a tablet computer, an Eko Duo device, a weight scale, a blood pressure cuff, a pulse oximeter

Find a Location

Who is running the clinical trial?

Saint Luke's Health SystemLead Sponsor
41 Previous Clinical Trials
12,916 Total Patients Enrolled

Media Library

Remote Patient Monitoring (VitalCare Platform) Clinical Trial Eligibility Overview. Trial Name: NCT05900362 — N/A
Congestive Heart Failure Research Study Groups: Interventional
Congestive Heart Failure Clinical Trial 2023: Remote Patient Monitoring Highlights & Side Effects. Trial Name: NCT05900362 — N/A
Remote Patient Monitoring (VitalCare Platform) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05900362 — N/A
~20 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top